Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 505

    1.

    Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

    Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E; Mexico City diabetes study.

    Diabetes Care. 2005 Jul;28(7):1757-62.PMID: 15983331 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study.

    Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Tanizaki Y, Shikata K, Iida M, Kiyohara Y.

    Obesity (Silver Spring). 2007 Jul;15(7):1841-50.PMID: 17636103 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.

    Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, Scaldaferri L, Di Bartolo P, Melandri P, Dei Cas A, Zavaroni I, Marchesini G.

    J Endocrinol Invest. 2008 Feb;31(2):146-52.PMID: 18362506 [PubMed - indexed for MEDLINE]Related articles

    4.

    Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

    Kim CH, Park JY, Lee KU, Kim JH, Kim HK.

    Diabetes Metab Res Rev. 2009 Jan;25(1):64-9.PMID: 19065605 [PubMed - indexed for MEDLINE]Related articles

    5.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Liver enzymes compared with alcohol consumption in predicting the risk of type 2 diabetes: the Kansai Healthcare Study.

    Sato KK, Hayashi T, Nakamura Y, Harita N, Yoneda T, Endo G, Kambe H.

    Diabetes Care. 2008 Jun;31(6):1230-6. Epub 2008 Mar 3.PMID: 18316395 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.

    Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Francesconi P, Buiatti E, Rotella CM, Mannucci E.

    Metabolism. 2008 Mar;57(3):387-92.PMID: 18249212 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

    Nakanishi N, Suzuki K, Tatara K.

    Diabetes Care. 2004 Jun;27(6):1427-32.PMID: 15161799 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.

    Perry IJ, Wannamethee SG, Shaper AG.

    Diabetes Care. 1998 May;21(5):732-7.PMID: 9589232 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.

    Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S.

    Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):253-9.PMID: 18074733 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Association of abnormality of liver enzymes and metabolic syndrome in patients with nonalcoholic fatty liver disease]

    Liu M, Yan HM, Gao X, Gao J.

    Zhonghua Yi Xue Za Zhi. 2007 Jan 23;87(4):253-5. Chinese. PMID: 17425870 [PubMed - indexed for MEDLINE]Related articles

    13.

    Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children.

    Lee YS, Kek BL, Poh LK, Saw SM, Loke KY.

    J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):172-8.PMID: 18664869 [PubMed - indexed for MEDLINE]Related articles

    14.

    Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress.

    Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F, Gentile L, Cassader M, Pagano GF.

    World J Gastroenterol. 2005 Dec 7;11(45):7109-17.PMID: 16437656 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

    Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E.

    J Endocrinol Invest. 2005 Apr;28(4):333-9.PMID: 15966506 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

    Wannamethee SG, Shaper AG, Lennon L, Whincup PH.

    Diabetes Care. 2005 Dec;28(12):2913-8.PMID: 16306554 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.

    Kim DJ, Noh JH, Cho NH, Lee BW, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW.

    Diabet Med. 2005 Sep;22(9):1134-40.PMID: 16108838 [PubMed - indexed for MEDLINE]Related articles

    18.

    The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults.

    Kang YH, Min HK, Son SM, Kim IJ, Kim YK.

    Diabetes Res Clin Pract. 2007 Aug;77(2):306-13. Epub 2007 Mar 13.PMID: 17353063 [PubMed - indexed for MEDLINE]Related articles

    19.

    The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.

    Mainous AG 3rd, Diaz VA, King DE, Everett CJ, Player MS.

    J Am Board Fam Med. 2008 Nov-Dec;21(6):497-503. Erratum in: J Am Board Fam Med. 2009 Mar-Apr;22(2):229. PMID: 18988716 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Decreased insulin secretion and insulin sensitivity are associated with liver function in subjects with fasting glucose between 100 and 109 mg/dL in Taiwanese population.

    Hsiao JY, Wang CL, Hsia PJ, Hsieh MC, Hsin SC, Lin KD, Shin SJ.

    Pancreas. 2007 Nov;35(4):343-7.PMID: 18090240 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data